Back

Prognostic value of baseline and follow-up ECG in patients with biopsy-proven fulminant myocarditis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Myocarditis: good tools for predicting bad outcomes Myocarditis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Michele Ciabatti

San Donato Hospital of Arezzo, Arezzo (Italy)

6 More presentations in this session

Presentation thumbnail
Novel risk scoring model to assess the need for venoarterial-extracorporeal membrane oxygenation in patients with acute myocarditis
Doctor D. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Baseline C-reactive protein as a predictor of non-ischemic LGE in myocarditis
Doctor M. Bernardi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Myocarditis in the modern era: analysing the impact of high-sensitivity troponin & C-reactive protein in predicting the extent of myocarditis and LV systolic dysfunction on cardiac magnetic resonance
Doctor Z. Hussein (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
Comparative evaluation of approach sites in right ventricular biopsy: influence on complication rates, particularly conduction defects.
Doctor S. Yoshida (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Adherence to sports counselling in middle-aged individuals with myocarditis
Mr J. Schuetze (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Myocarditis: good tools for predicting bad outcomes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Electrocardiogram characteristics and long-term follow-up outcomes of 115 children with fulminant myocarditis
thumbnail
Congress Presentation
Independent predictors of dismal and favourable outcome in adult and paediatric myocarditis: data from the multicentric Italian Rare Biopsy-proven Myocarditis Registry
thumbnail
Congress Presentation
Acute myocarditis, a hidden disease: trying to describe diagnostic workflows and to predict mid term outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources